A detailed history of Centric Wealth Management transactions in Maia Biotechnology, Inc. stock. As of the latest transaction made, Centric Wealth Management holds 68,219 shares of MAIA stock, worth $137,802. This represents 0.05% of its overall portfolio holdings.

Number of Shares
68,219
Previous 68,198 0.03%
Holding current value
$137,802
Previous $233,000 18.03%
% of portfolio
0.05%
Previous 0.07%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.54 - $3.87 $53 - $81
21 Added 0.03%
68,219 $191,000
Q2 2024

Aug 13, 2024

BUY
$1.96 - $5.1 $1,960 - $5,100
1,000 Added 1.49%
68,198 $233,000
Q4 2023

Feb 06, 2024

BUY
$0.83 - $2.54 $2,109 - $6,456
2,542 Added 3.93%
67,198 $78,000
Q3 2023

Nov 03, 2023

BUY
$1.42 - $2.41 $284 - $482
200 Added 0.31%
64,656 $142,000
Q2 2023

Aug 14, 2023

BUY
$2.11 - $3.84 $51,167 - $93,120
24,250 Added 60.31%
64,456 $141,000
Q4 2022

Jan 04, 2023

BUY
$3.1 - $3.85 $124,638 - $154,793
40,206 New
40,206 $0

Others Institutions Holding MAIA

About MAIA Biotechnology, Inc.


  • Ticker MAIA
  • Exchange
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 10,935,900
  • Market Cap $22.1M
  • Description
  • MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...
More about MAIA
Track This Portfolio

Track Centric Wealth Management Portfolio

Follow Centric Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centric Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Centric Wealth Management with notifications on news.